Publication dates

Heart Failure Industry, July 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, chronic heart failure, therapeutics, more »


 
1-10 of 88 reports for Heart Failure

Chronic Heart Failure - Pipeline Review, H2 2014

Chronic Heart Failure - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of chronic heart failure- the report reviews key pipeline products under drug profile section which includes, product description, mo ...

 Chronic Heart Failure Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Chronic Heart Failure Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of chronic heart failure key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

 Acute Heart Failure Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Acute Heart Failure Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... And exclusivity details of acute heart failure key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under ...

Astute Medical, Inc. - Product Pipeline Analysis, 2014 Update

Astute Medical, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... As the basis for in vitro diagnostic tests. It develops diagnostic tests for therapeutic areas such as ominal pain, acute coronary syndromes, cerebrovascular injury, congestive heart failure, acute kidney ...

Pronota NV - Product Pipeline Analysis, 2014 Update

Pronota NV - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Threatening conditions and unmet medical conditions. The company provides diagnostics for heart failure, pre-eclampsia and sepsis. The company has four programs in its pipeline which includes protein diagnostic blood ...

ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Respiratory failure (arf), acute respiratory distress syndrome (ards), congestive heart failure with pulmonary edema and neonatal respiratory distress syndrome. Alung is headquartered in pittsburgh ...

Dilated Cardiomyopathy - Pipeline Review, H1 2014

Dilated Cardiomyopathy - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Milestones 39featured news & press releases 39apr 02, 2014: fda grants ind approval for phase iia clinical trial using cardiocell's itmsc therapy to treat dilated chronic heart failure 39dec 19 ...

 Congestive Heart Failure (Heart Failure)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Congestive Heart Failure (Heart Failure)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... failure) key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

Stereotaxis, Inc. (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stereotaxis, Inc. (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

... Of arrhythmias, heart failure, and coronary artery disease. Through its direct sales force, distributors and sales agents, the company markets its products in the us, europe and other parts of the world ...

Amarantus Bioscience Holdings, Inc. (AMBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amarantus Bioscience Holdings, Inc. (AMBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

... For neurodegenerative diseases such as parkinson's disease, als and alzheimer's disease, and cardiovascular diseases including myocardial infarction, coronary artery disease and heart failure. The company holds license ...

About 3 100 reports for Heart Failure

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Risk Factors for Hospital Admission among Older Persons with New...
  • January 2012
    8 pages
  • Heart Failure  

    Hospital  

  • United States  

View report >

2 Companies for Heart Failure

Read our Company Profiles

Select Products Inc.

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.